| Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology J Hrenak, L Paulis, S Fedor International Journal of Molecular Sciences, 2016 | 119 | 2016 |
| Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol‐induced heart failure F Simko, KR Bednarova, K Krajcirovicova, J Hrenak, P Celec, ... Journal of Pineal Research 57 (2), 177-184, 2014 | 96 | 2014 |
| Melatonin and renal protection: novel perspectives from animal experiments and human studies J Hrenak, L Paulis, K Repova, S Aziriova, E J Nagtegaal, R J Reiter, ... Current pharmaceutical design 21 (7), 936-949, 2015 | 75 | 2015 |
| Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome J Hrenak, F Simko International Journal of Molecular Sciences 21 (12), 8038, 2020 | 70 | 2020 |
| Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats J Hrenak, K Arendasova, R Rajkovicova, S Aziriová, K Repová, ... Physiol Res 62 (Suppl 1), S181-S189, 2013 | 67 | 2013 |
| Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril S Aziriova, KR Bednarova, K Krajcirovicova, J Hrenak, R Rajkovicova, ... Pharmacology Biochemistry and Behavior 124, 284-289, 2014 | 46 | 2014 |
| Effect of captopril and melatonin on fibrotic rebuilding of the aorta in 24 hour light-induced hypertension K Repová-Bednárová, S Aziriová, J Hrenák, K Krajcíroviová, M Adamcová, ... Physiological Research 62, S135, 2013 | 37 | 2013 |
| Melatonin as a putative protection against myocardial injury in COVID-19 infection F Simko, J Hrenak, A Dominguez-Rodriguez, RJ Reiter Expert review of clinical pharmacology 13 (9), 921-924, 2020 | 27 | 2020 |
| Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions F Simko, J Hrenak, M Adamcova, L Paulis International Journal of Molecular Sciences, 2021 | 26 | 2021 |
| N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain J Hrenak, L Paulis, F Simko Current pharmaceutical design 21 (35), 5135-5143, 2015 | 26 | 2015 |
| Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril K Repova, P Stanko, T Baka, K Krajcirovicova, S Aziriova, J Hrenak, ... Frontiers in Pharmacology 13, 978337, 2022 | 5 | 2022 |
| Renin-angiotensin system and SARS-CoV-2 interaction: Underlying mechanisms and potential clinical implications J Hrenak, S Zorad, F Simko General Physiology and Biophysics 39 (3), 203-204, 2020 | 4 | 2020 |
| Dual inhibition of neprilysin and angiotensin II type 1 receptor in light of clinical studies T Baka, P Stanko, J Hrenák, A Dukát, F Šimko Cardiology Letters 30 (1), 23-30, 2021 | 1 | 2021 |
| Používanie ibuprofénu a inhibítorov ACE u pacientov s COVID-19 J Hrenák, K Repová | | 2020 |
Ludovit PaulisInstitute of Pathophysiology, Faculty of Medicine, Comenius University, BratislavaEmail verificata su fmed.uniba.sk